Construction of cholera toxin B subunit-producingVibrio choleraestrains using theMariner-FRT transposon delivery system
Authors:
Open Access
- 1 January 2008
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 52 (1) , 23-28
Abstract
The most widely used oral whole-cell-recombinant B subunit cholera vaccine contains the nontoxic cholera toxin B subunit (CTXB) and either heat- or fKeywords
This publication has 30 references indexed in Scilit:
- Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infantsVaccine, 2007
- Randomized, Controlled Study of the Safety and Immunogenicity of Peru‐15, a Live Attenuated Oral Vaccine Candidate for Cholera, in Adult Volunteers in BangladeshThe Journal of Infectious Diseases, 2005
- Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNAImmunology Letters, 2005
- The ompU Paralogue vca1008 Is Required for Virulence of Vibrio choleraeJournal of Bacteriology, 2004
- The intracellular voyage of cholera toxin: going retroTrends in Biochemical Sciences, 2003
- Construction of a Vibrio cholerae Vaccine Candidate Using Transposon Delivery and FLP Recombinase-Mediated ExcisionInfection and Immunity, 2000
- In Vitro and In Vivo Analyses of Constitutive and In Vivo-Induced Promoters in Attenuated Vaccine and Vector Strains of Vibrio choleraeInfection and Immunity, 2000
- Affinity purification of recombinant cholera toxin B subunit oligomer expressed inBacillus brevisfor potential human use as a mucosal adjuvantFEMS Immunology & Medical Microbiology, 1998
- Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-upThe Lancet, 1990
- A Broad Host Range Mobilization System for In Vivo Genetic Engineering: Transposon Mutagenesis in Gram Negative BacteriaBio/Technology, 1983